Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review.
about
Markers of resistance to anti-EGFR therapy in colorectal cancerRecent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal CancerKRAS mutational concordance between primary and metastatic colorectal adenocarcinoma.Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.Acquired drug resistance conferred by a KRAS gene mutation following the administration of cetuximab: a case report.Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug.Heterogeneity of KRAS Mutation Status in Rectal CancerEZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cellsEfficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidencePodocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.Somatic mutation profiles in primary colorectal cancers and matching ovarian metastases: Identification of driver and passenger mutations.Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond.Tumour heterogeneity: principles and practical consequences.Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the pieNeoadjuvant chemotherapy affects molecular classification of colorectal tumors.KRAS mutation status is highly homogeneous between areas of the primary tumor and the corresponding metastasis of colorectal adenocarcinomas: one less problem in patient care.Addition of RAS Mutation Status May Strengthen the Predictive Model for Progression of Indeterminate Pulmonary NodulesIntegrating anti-EGFR therapies in metastatic colorectal cancer.RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group.Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?Colorectal cancer: using blood samples and tumor tissue to detect K-ras mutations.Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer.Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?
P2860
Q24598640-ED06398C-18F7-43DD-A617-9743992528D7Q33624491-7BF390C3-081A-4812-ADC1-19C66800E1AAQ34141770-EB7816DD-8622-482A-A9BE-B4BB7CB7F4F5Q34371471-5E427BE2-FE7D-408F-BB9A-A60BE4663878Q35058994-1FA04744-6990-415C-A65F-E04CDFD5E24CQ35904508-68866AD5-39BC-481C-A828-6D94515C6294Q35985611-875839D9-CAF3-4063-872D-97B074FA0569Q36212878-C4F56F94-B366-4C0C-8582-B0F3EC135FE3Q36250585-B5D7BDF5-E41E-41E3-8FE7-3A2B2B7A0BD8Q37114865-8D5E29B9-19B7-4D9D-ABA5-127D50510E0DQ37121274-E64EA90E-5389-4ED4-B77E-74964D01DEC6Q37687424-CFDF2565-8CDB-450A-BEEE-CCDD92C41B6BQ38136134-C2AABCE1-BDBF-4A04-85B4-7C53B2FBBFD3Q38842168-7EA058FA-FD17-4F36-B49E-8217B9C5ADD2Q39172118-27F3C6C4-1111-4DFC-AFF9-367BAFE3227DQ41228722-0D2EA4C6-D3DA-446C-A41F-C9C2A5488D35Q41980098-170D523F-AA86-4259-AAE9-A1AC82A3D23AQ42414950-20790382-A0ED-4969-A614-13E0D5317DE6Q43090496-633AB61A-9A4A-4DAC-903E-DC6701778383Q43531971-C0C4865E-186A-4605-BA31-0A6D9E897D29Q51033072-131479B5-F370-439B-B9A4-E98BFC0A448AQ53482447-65ABB0D3-203A-4490-BBBE-94D7A2DE7BDFQ53795029-B823FB95-65F6-403B-95F3-B9A3B7F255C7Q58780717-AFDF78DA-58F4-49BB-90D9-D660F34C6A37
P2860
Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Concordant KRAS mutations in p ...... nalysis and systematic review.
@en
type
label
Concordant KRAS mutations in p ...... nalysis and systematic review.
@en
prefLabel
Concordant KRAS mutations in p ...... nalysis and systematic review.
@en
P2093
P2860
P1433
P1476
Concordant KRAS mutations in p ...... nalysis and systematic review.
@en
P2093
Cheng-Bo Han
Hua-Wei Zou
Jie-Tao Ma
P2860
P304
P356
10.3109/07357907.2012.732159
P577
2012-10-17T00:00:00Z